Abbott Extends Antibody Target Deal With Caprion
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott adds two years to exclusive agreement for rights to 10 NSCLC targets identified by Canadian proteomics firm.
You may also be interested in...
Lilly Acquires ICOS To Bring Full Value Of Cialis In House
$2.1 bil. deal will allow Lilly to benefit from efficiencies in development, marketing and sales of the erectile dysfunction product.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
Alzheimer’s, BRAIN Initiative Highlighted In $30 Billion NIH Budget Proposal
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.